Leads Biolab
Stage
Series C - II | AliveTotal Raised
$179.78MLast Raised
$100M | 1 yr agoAbout Leads Biolab
Leads Biolab is an antibody-drug developer, mainly engaged in the research and development of original antibody drugs for anti-tumor, treatment of autoimmune or infectious diseases, and more.
Missing: Leads Biolab's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Leads Biolab's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Leads Biolab
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Leads Biolab is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Leads Biolab Frequently Asked Questions (FAQ)
Where is Leads Biolab's headquarters?
Leads Biolab's headquarters is located at 7th Floor, Building 3, No. 18, Jialingjiang East Street, Jianye District, Nanjing.
What is Leads Biolab's latest funding round?
Leads Biolab's latest funding round is Series C - II.
How much did Leads Biolab raise?
Leads Biolab raised a total of $179.78M.
Who are the investors of Leads Biolab?
Investors of Leads Biolab include Hygeia Capital, Ennovation VC, NSR Financial, AJS Securities, Hankang Equity Investment Management and 20 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.